These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 399234)

  • 21. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
    Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of blood pressure by the renin-angiotensin system in normal man.
    MacGregor GA; Markandu ND; Roulston JE; Jones JC; Morton JJ
    Nature; 1981 May; 291(5813):329-31. PubMed ID: 7015149
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of angiotensin II in the regulation of aldosterone biosynthesis.
    McCaa RE; Guyton AC; Young DB; McCaa CS
    Adv Exp Med Biol; 1980; 130():227-55. PubMed ID: 6250341
    [No Abstract]   [Full Text] [Related]  

  • 24. [The significance of renin-angiotensin-aldosterone system (RAA) in pathophysiology and diagnosis].
    Kokot F
    Przegl Lek; 1972; 29(4):453-7. PubMed ID: 4338193
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
    Riegger GA; Steilner H; Hayduk K; Liebau G
    Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
    Cottone S; Grasso L; D'Ignoto G; Contorno A; Ziletti T; Carapelle E; Carone MB; Fulantelli MA; Cerasola G
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):803-10. PubMed ID: 2833914
    [No Abstract]   [Full Text] [Related]  

  • 29. [The pressor and adrenal responses to angiotensin II in patients with normoreninemic essential hypertension--the influence of sodium intake and captopril].
    Kuroda K; Ito K; Sakaguchi A; Kimura G; Uda M; Kojima S; Natsume T; Sakamoto N; Tsuchiya M; Tanaka T
    Nihon Jinzo Gakkai Shi; 1983 Feb; 25(2):179-88. PubMed ID: 6353007
    [No Abstract]   [Full Text] [Related]  

  • 30. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
    Kumagai H; Suzuki H; Ichikawa M; Matsumura Y; Jimbo M; Ryuzaki M; Saruta T
    Circ Res; 1993 Jun; 72(6):1255-65. PubMed ID: 8495554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between aldosterone and bradykinin.
    Mersey JH; Williams GH; Hollenberg NK; Dluhy RG
    Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological effects of captopril].
    Rubin B; Antonaccio J
    Nouv Presse Med; 1981 Apr; 10(19):1531-46. PubMed ID: 6269555
    [No Abstract]   [Full Text] [Related]  

  • 33. Captopril in renovascular hypertension: long-term use in predicting surgical outcome.
    Atkinson AB; Brown JJ; Cumming AM; Fraser R; Lever AF; Leckie BJ; Morton JJ; Robertson JI
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):689-93. PubMed ID: 6802290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on hypertension: I) The effects of angiotensin II and norepinephrine infusion on renal hemodynamics and renin angiotensin system in anesthetized dogs. II) The metabolism of 3H-DOPA in two kidney Goldblatt dogs (author's transl)].
    Kita T
    Nihon Jinzo Gakkai Shi; 1978 Aug; 20(8):931-41. PubMed ID: 713169
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of aldosterone in experimental hypertension.
    McCaa RE; McCaa CS; Bengis RG; Guyton AC
    J Endocrinol; 1979 May; 81(2):69P-78P. PubMed ID: 222873
    [No Abstract]   [Full Text] [Related]  

  • 36. The renin-angiotensin-aldosterone system in hypertension: its biochemistry and applications.
    Lijnen P; Amery A; Fagard R; Reybrouck T
    Acta Clin Belg; 1979; 34(4):226-45. PubMed ID: 525202
    [No Abstract]   [Full Text] [Related]  

  • 37. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of the angiotensin II antagonist saralasin on blood pressure and plasma aldosterone in man in relation to the prevailing plasma angiotensin II concentration.
    Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM
    Prog Biochem Pharmacol; 1976; 12():230-41. PubMed ID: 1019166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of aldosterone biosynthesis by sodium sequestration: role of angiotensin II.
    Müller J; Lund EG; Hofstetter L; Brunner DB; Haldy P
    Am J Physiol; 1982 Dec; 243(6):E450-7. PubMed ID: 6756162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal and renal responses to converting enzyme inhibition during maximal exercise.
    Wade CE; Ramee SR; Hunt MM; White CJ
    J Appl Physiol (1985); 1987 Nov; 63(5):1796-800. PubMed ID: 2826383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.